#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Eric Vandal Email
Sr. VP, Commercial Operations . Cara Therapeutics
How to contact Eric Vandal
Join and see Eric's contact info for free!Current Roles
Employees:
102Revenue:
$29.4MAbout
Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat pain, inflammation and pruritus. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's most advanced patented compound, CR845, is currently undergoing clinical testing for acute pain and uremic pruritus. This compound possesses analgesic, anti-inflammatory and antipruritic activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.Cara Therapeutics Address
107 Elm StreetStamford, null
United States